COVID-19 vaccines are not dangerous for the vast majority of people who receive them. In clinical trials and real-world monitoring of billions of doses administered worldwide, most side effects were mild to moderate and resolved within one to three days. Serious adverse events do exist but are rare, occurring in single-digit cases per million doses. Here’s what the evidence actually shows, broken down by the risks people worry about most.
Common Side Effects
The side effects most people experience after a COVID-19 vaccine are the same ones you’d expect from a flu shot, just sometimes a bit more noticeable. Pain and soreness at the injection site are the most frequent. Beyond that, fatigue, headache, muscle pain, joint pain, chills, and fever all show up regularly. Younger children may be more irritable, sleepy, or lose their appetite for a day or two. These reactions signal that your immune system is responding to the vaccine, and they typically clear up within one to three days.
Second doses and booster doses tend to produce stronger reactions than first doses. Younger adults generally report more side effects than older adults, though the pattern varies by vaccine manufacturer. None of these common reactions are considered medically concerning.
Myocarditis and Pericarditis
Heart inflammation is the serious side effect that has gotten the most attention, and it’s worth understanding the actual numbers. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining around the heart) have been linked to mRNA vaccines, particularly in younger males after the second dose. The overall rate is about 12.6 cases per million second doses among people aged 12 to 39.
The risk is not evenly distributed. Males aged 12 to 17 had the highest reporting rate at about 66.7 cases per million second doses. For males 18 to 24, the rate was 56.3 per million second doses. By comparison, females in the same age groups had rates of 9.1 and 5.5 per million second doses, respectively. For people over 50, the rates drop to low single digits per million for both sexes.
Context matters here. A major study comparing vaccine-related and infection-related heart inflammation in children and young people found that COVID-19 infection itself caused roughly 2.24 extra cases of myocarditis or pericarditis per 100,000 people, while vaccination caused about 0.85 extra cases per 100,000. In other words, catching COVID carried roughly 2.5 times the heart inflammation risk compared to getting vaccinated. The vaccine-associated risk was also limited to the first four weeks after the shot, with no increased risk observed beyond that window. Most vaccine-related myocarditis cases have been mild and responded well to treatment.
Anaphylaxis
Severe allergic reactions to COVID-19 vaccines happen, but they’re extremely uncommon. Confirmed anaphylaxis rates are roughly 2.5 to 5 cases per million doses, depending on the vaccine product. For comparison, anaphylaxis occurs with many common medications and other vaccines at similar or higher rates. Vaccination sites are equipped to treat anaphylaxis immediately, which is why you’re asked to wait 15 minutes after your shot.
Blood Clots With the AstraZeneca Vaccine
A rare clotting condition called thrombosis with thrombocytopenia syndrome was identified in people who received the AstraZeneca (viral vector) vaccine, at a rate of roughly 2 to 3 cases per 100,000 vaccinated people. This was a serious finding, and it led to the withdrawal of the AstraZeneca vaccine in multiple countries. Australia pulled it from use in March 2023. The vaccines currently available in the United States are mRNA vaccines (Pfizer and Moderna) and a protein subunit vaccine (Novavax), none of which have been linked to this clotting syndrome.
Guillain-Barré Syndrome
Guillain-Barré syndrome, a condition where the immune system attacks nerve cells and causes weakness or paralysis, has been reported after COVID-19 vaccination. A systematic review identified 175 cases across published reports, with the majority occurring after the AstraZeneca or Pfizer vaccines. The adenoviral vector vaccines (like AstraZeneca and Johnson & Johnson) showed a stronger association than mRNA vaccines. This remains an extremely rare event relative to the billions of doses given, though it’s one reason the viral vector vaccines fell out of favor.
Fertility and Pregnancy
One of the most persistent concerns about COVID-19 vaccines has been whether they affect fertility or pregnancy outcomes. The data consistently shows they do not. A study of more than 2,000 women aged 21 to 45 and their partners found that vaccination of either partner did not affect the likelihood of becoming pregnant. Studies of patients undergoing in vitro fertilization found no difference in pregnancy success rates between vaccinated and unvaccinated women.
In men, a study of 45 healthy men who received an mRNA vaccine found no significant changes in sperm quantity or movement after vaccination. Some women have reported small, temporary changes to their menstrual cycles after vaccination, including slightly longer periods or heavier bleeding. These changes are short-lived and have not been linked to any effect on fertility.
Thousands of women who received COVID-19 vaccines before or during early pregnancy have been tracked through safety monitoring systems, with no concerning patterns in miscarriage rates or birth outcomes.
How Vaccine Safety Is Tracked
You may have seen claims based on VAERS (the Vaccine Adverse Event Reporting System), which is a public database where anyone can submit a report of a health event that happened after vaccination. VAERS is useful as an early warning system, but it has a critical limitation: it cannot determine whether the vaccine actually caused the reported event. Someone could have a heart attack two weeks after vaccination and it would appear in VAERS, even if the vaccine played no role. Reports may also contain errors or lack key details.
When VAERS flags a potential signal, other systems investigate whether the link is real. The Vaccine Safety Datalink covers more than 24 million patients across thirteen healthcare systems and can compare rates of health problems between vaccinated and unvaccinated people. PRISM, the largest vaccine safety surveillance system in the country, has access to data on over 190 million people through health insurance claims. The v-safe program used smartphone-based check-ins to track how people felt after their shots in real time. Together, these overlapping systems make the U.S. vaccine safety monitoring infrastructure one of the most comprehensive in the world.
Putting the Risks in Perspective
Every medical intervention carries some degree of risk, and COVID-19 vaccines are no exception. The serious risks that have been confirmed, primarily myocarditis in young males and the now-discontinued AstraZeneca clotting issue, are real but rare, measured in single-digit to low double-digit cases per million doses. The most common experience after vaccination is a sore arm and a day of feeling run down.
The vaccines currently available have been monitored across billions of administered doses globally. The risk profile has led to specific guidance, such as awareness of myocarditis symptoms in young males, rather than broad safety concerns. For the large majority of people, the known risks of COVID-19 infection, including its own higher rate of heart inflammation, lung damage, and long-term symptoms, remain substantially greater than the risks posed by vaccination.